Last reviewed · How we verify
NCT03963830: MOVEUP-S
Sustainability of MOVE UP Lifestyle Intervention
NA trial testing MOVE UP in Body Weight in 15 participants. Completed in 30 December 2019.
30 October 2019
Quick facts
| Lead sponsor | University of Pittsburgh |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 15 |
| Start date | 19 June 2019 |
| Primary completion | 30 October 2019 |
| Estimated completion | 30 December 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MOVE UP
Conditions studied
- Body Weight — all drugs for Body Weight →
- Diet, Healthy — all drugs for Diet, Healthy →
- Physical Disability — all drugs for Physical Disability →
Sponsor
University of Pittsburgh
Who can join
Adults 60 to 75, any sex, with Body Weight or Diet, Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In prior research the investigators have shown that the Mobility and Vitality Lifestyle Program for healthy aging and weight management (MOVE UP) was effective in producing a mean loss of \>= 5% body weight, with increased physical activity and reduced fatigue. The current study will pilot a modified and streamlined program to see if it will be similarly effective.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03963830
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MOVE UP
Trials testing the same drug.
- NCT03967912 — MOVE UP Lifestyle Intervention for Caregivers · NA · completed
- NCT02657239 — Mobility & Vitality Lifestyle Program · NA · completed
Other recruiting trials for Body Weight
Currently open trials in the same condition.
- NCT07306793 — The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body We · NA · recruiting
- NCT06169137 — Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and Immunoregulation · NA · recruiting
- NCT06387901 — Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition. · recruiting
- NCT06409962 — A New Technological Intervention to Address Childhood Obesity: · NA · recruiting
- NCT06406192 — Effects of FOR-Care Model on Preventive Medicine · NA · active not recruiting
Other University of Pittsburgh trials
Trials by the same sponsor.
- NCT05601206 — Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE · NA · not yet recruiting
- NCT06652815 — Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation · not yet recruiting
- NCT06474286 — Prucalopride for Cognitive Functioning in Schizophrenia · NA · not yet recruiting
- NCT06488469 — Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus · NA · not yet recruiting
- NCT06652802 — Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03963830 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pittsburgh
- Last refreshed: 2 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03963830.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing